Tuesday, 23 Jan 2018

You are here

Educational Intervention Facilitates Treat-to-Target Management in Rheumatoid Arthritis

Treat-to-target (TTT) has become a goal in rheumatoid arthritis (RA) therapeutics, but its implementation in daily practice is varied and viewed to be difficult by most. Solomon and coworkers have shown that TTT education through group-based quality improvement sessions can result in wider use of TTT in practice.

They set out to study the adherence to TTT in practice using a randomized quality improvement intervention with wait-list control across 11 rheumatology sites in the US.

The intervention utilized was a "learning collaborative" effort to establish best practices. These group-based learning collaboratives used rapid cycle testing for change along with frequent assessment of quality care improvements.

For 9-months the LC group incorporated rapid-cycle improvement methods. A composite TTT implementation score was a percentage of four required items documented in the chart. These included: 1) a disease activity target; 2) recording RA disease activity,numerically or by category (i.e., remission, low disease activity, etc.) using either the DAS28, SDAI, CDAI, or RAPID3; 3) documenting shared-decision making; and 4) documenting treatment decisions based on target and disease activity measure.

Five sites (23 providers) were randomized to intervention  and managed 320 patients, while six sites (23 provider) were randomized to the wait-list control, managing 321 patients.

At study start a minority utilized TTT with mean TTT implementation score of 11%.  After  9 months, the TTT implementation score was higher with the LC intervention (57% vs 25% in control).

Substantial improvement in TTT utilization was seen with this learning collaborative intervention.  

While nearly half of all rheumatologists utilize some disease measure in practice, there is little evidence that they utilize this information in daily patient management.  These findings suggest that knowing and using the measure in the clinic may not be enough and that a substantial committment to quality care and specific educational interventions are needed to demonstrate treatment decisions based on disease activity measures in RA.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Weight Loss Linked to RA Improvement

By retrospectively reviewing electronic health record (EHR) data, Kreps et al found that rheumatoid arthritis (RA) patients who lost >5 kg of weight were three times more likely to demonstrate improvement in disease activity.

Researchers investigated the association between weight loss and CDAI change among patients who were overweight/obese at baseline and who lost weight during follow-up.

IL-1 and IL-6 Inhibition Preferred in Systemic JIA

Since 2000, the German Biologics register (BiKeR) has prospectively enrolled children with juvenile idiopathic arthritis to assess outcomes with biologic therapies.  A new report evaluates the efficacy and safety of etanercept (ETA), tocilizumab (TOC) and the interleukin-1 inhibitors (anakinra and canakinumab) (IL-1i) in those with systemic onset juvenile idiopathic arthritis JIA (sJIA).

Increasing Adverse Events Seen with Higher Disease Activity in Early RA

Researchers in the NEO-RACo Study Group studied adverse events (AEs) in relation to disease activity in patients with early rheumatoid arthritis (RA).

Small Joint Surgeries Drop Among RA Patients

The rate of small - but not large - joint surgery has dropped among patients with rheumatoid arthritis since 1995, a retrospective review of orthopedic surgeries found. By 2015, less than 1% of patients per year underwent small joint surgery, reported Ashima Makol, MD, of the Mayo Clinic in Rochester, Minnesota, and colleagues in Arthritis Care & Research. 

Despite Increasing Metric Use, They Are Not Widespread in Rheumatoid Care

The Journal of Rheumatology has published a nationwide survey of US rheumatologists and shown that despite trends for increasing metric assessments, nearly half of rheumatoid arthritis (RA) patients are not routinely assessed with a disease activity metric and the evidence they use these in a treat-to-target (T2T) practice is lacking.